MoneyWorks4Me

Caplin Point Laboratories informs about press release

24 Sep 2021 Evaluate

Caplin Point Laboratories has informed that it enclosed a press release titled ‘Caplin Point's CRO Amaris Clinical completes USFDA audit with nil observations’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..